Abaxis (Abaxis) FCF Margin % : 7.51% (As of Mar. 2018)

View and export this data going back to 1992. Start your Free Trial

What is Abaxis FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Abaxis's Free Cash Flow for the three months ended in Mar. 2018 was $5.1 Mil. Abaxis's Revenue for the three months ended in Mar. 2018 was $67.9 Mil. Therefore, Abaxis's FCF Margin % for the quarter that ended in Mar. 2018 was 7.51%.

As of today, Abaxis's current FCF Yield % is 1.96%.

The historical rank and industry rank for Abaxis's FCF Margin % or its related term are showing as below:

ABAX' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 15.31
Current: 15.31

During the past 13 years, the highest FCF Margin % of Abaxis was 15.31%. The lowest was 0.00%. And the median was 0.00%.

ABAX's FCF Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -10.405 vs ABAX: 15.31

Abaxis FCF Margin % Historical Data

The historical data trend for Abaxis's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis FCF Margin % Chart

Abaxis Annual Data

Trend

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

FCF Margin %

Get a 7-Day Free Trial

18.53

14.97

10.45

10.11

15.31

Abaxis Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
FCF Margin %	Get a 7-Day Free Trial															14.99	16.56	19.48	18.86	7.51

Competitive Comparison of Abaxis's FCF Margin %

For the Diagnostics & Research subindustry, Abaxis's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abaxis's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Abaxis's FCF Margin % falls into.

Abaxis FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Abaxis's FCF Margin for the fiscal year that ended in Mar. 2018 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2018 )	/	Revenue (A: Mar. 2018 )
	=	37.47	/	244.7
	=	15.31 %

Abaxis's FCF Margin for the quarter that ended in Mar. 2018 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2018 )	/	Revenue (Q: Mar. 2018 )
	=	5.104	/	67.918
	=	7.51 %

Abaxis FCF Margin % Related Terms

Thank you for viewing the detailed overview of Abaxis's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abaxis (Abaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.abaxis.com

Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.

Executives

Richard Bastiani	director	C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr	officer: CFO and VP of Finance	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson	director, officer: CEO & Board Chairman	C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey	director	ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020